Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Tools & Techniques

Tools & Techniques Diagnostics & prognostics

Garbage In, Garbage Out

| Carolyn Compton

Preanalytical variability can be a hidden danger in skewing test results. What's the best way to detect and overcome it?

Tools & Techniques Drug discovery

Medicina Ex Machina

| Roisin McGuigan

Artificial intelligence could have a huge impact on drug discovery.

Tools & Techniques Omics

The Diagnostic Power of DNA Methylation

| Bekim Sadikovic

Machine learning and DNA methylation could open up a new realm of diagnostic possibility

Tools & Techniques Omics

Translational Proteomics: Solving the Reproducibility Riddle

| David Chiang

Data analysis in proteomics is not fit for purpose – but here’s how we can get on track

Tools & Techniques Cancer

The Esophageal Balloon

| Sanford Markowitz

The story behind an inflatable pill and a sensitive biomarker that pair up to improve screening for Barrett’s esophagus – and help prevent a highly aggressive cancer

Tools & Techniques Diagnostics & prognostics

The Truth About Personal Genetic Tests

| Suneel Deepak Kamath

Is direct-to-consumer testing anywhere near as useful as it appears to the public – or to science?

Tools & Techniques Omics

Metabolomics: the Superglue of Omics

| Martin Giera, Mary E. Spilker, Gary Siuzdak

As the profile of metabolomics soars, we offer our thoughts on the future of the field.

Tools & Techniques Clinical trials

Cherchez la Femme?

| Roisin McGuigan

A review of FDA data suggests that women are now better represented in clinical trials.

Tools & Techniques Neuroscience

Sniffing Out a Test for Parkinson’s

A woman who can identify people with Parkinson’s by smell is helping scientists pinpoint molecules

Tools & Techniques Drug discovery

Adopting an Orphan (Drug)

| Pan Pantziarka and Gauthier Bouche

New cancer treatments may be lying right under our noses – if we are willing to take a commercial risk.

Newsletter

Send me the latest from The Translational Scientist.

Sign up now

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register